Because many of the enzymes, receptors, and signaling molecules that mediate these processes are subject to pharmacologic interventions, our long-term goal is to use the information gleaned from these studies to devise treatments for neurodegenerative or psychological brain diseases in humans, such as Alzheimer???s diseases, Parkinson???s disease, mental retardation and emotional deficits.